{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:43:14Z","timestamp":1773517394319,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100022110","name":"bioM\u00e9rieux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10096-025-05361-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:26:39Z","timestamp":1763731599000},"page":"787-796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recovery of nontuberculous mycobacteria from non-cystic fibrosis respiratory specimens using a decontamination-free selective agar"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4110-3263","authenticated-orcid":false,"given":"Tina I.","family":"Bui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie R.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-8134","authenticated-orcid":false,"given":"Carol E.","family":"Muenks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Orenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-7552","authenticated-orcid":false,"given":"Melanie L.","family":"Yarbrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-8407","authenticated-orcid":false,"given":"Allison R.","family":"Eberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"5361_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","volume":"17","author":"KL Winthrop","year":"2020","unstructured":"Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q (2020) Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008\u20132015. Ann Am Thorac Soc 17:178\u2013185","journal-title":"Ann Am Thorac Soc"},{"key":"5361_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, B\u00f6ttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL (2020) Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis 71:e1\u2013e36","journal-title":"Clin Infect Dis"},{"key":"5361_CR3","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/microorganisms9081597","volume":"9","author":"D Stephenson","year":"2021","unstructured":"Stephenson D, Perry A, Nelson A, Robb AE, Thomas MF, Bourke SJ, Perry JD, Jones AL (2021) Decontamination strategies used for AFB culture significantly reduce the viability of Mycobacterium abscessus complex in sputum samples from patients with cystic fibrosis. Microorganisms 9:1597","journal-title":"Microorganisms"},{"key":"5361_CR4","doi-asserted-by":"publisher","unstructured":"Wengenack NL (2023) Solid media used for isolation. In: Leber\u00a0AL, Burnham C-AD (eds) Clinical microbiology procedures handbook, 5th edn. John Wiley & Sons, Ltd., vol 9.3, pp 1\u20134.\u00a0https:\/\/doi.org\/10.1002\/9781683670438.cmph0092","DOI":"10.1002\/9781683670438.cmph0092"},{"key":"5361_CR5","doi-asserted-by":"publisher","unstructured":"Pfeltz RF, Wengenack NL (2023) Liquid media used for isolation. In: Leber\u00a0AL, Burnham C-AD (eds) Clinical microbiology procedures handbook, 5th edn. John Wiley & Sons, Ltd, vol 9.4.1, pp 1\u201312.\u00a0https:\/\/doi.org\/10.1002\/9781683670438.cmph0093","DOI":"10.1002\/9781683670438.cmph0093"},{"key":"5361_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12890-019-0781-2","volume":"19","author":"D Stephenson","year":"2019","unstructured":"Stephenson D, Perry A, Appleby MR, Lee D, Davison J, Johnston A, Jones AL, Nelson A, Bourke SJ, Thomas MF, De Soyza A, Lordan JL, Lumb J, Robb AE, Samuel JR, Walton KE, Perry JD (2019) An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation. BMC Pulm Med 19:19","journal-title":"BMC Pulm Med"},{"key":"5361_CR7","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1128\/jcm.00036-23","volume":"61","author":"A Broncano-Lavado","year":"2023","unstructured":"Broncano-Lavado A, Barrado L, Lopez-Roa P, Cacho J, Domingo D, Hernandez S, Garcia-Martinez J, Millan MR, Perez-Cecilia E, Ruiz-Serrano M-J, Salso S, Simon M, Tato M, Toro C, Valverde-Canovas JF, Esteban J (2023) Clinical evaluation of nontuberculous mycobacteria (NTM) elite Agar, a new medium for the isolation of NTM: a multicenter study. J Clin Microbiol 61:e00036\u2013e00023","journal-title":"J Clin Microbiol"},{"key":"5361_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01678-23","volume":"0","author":"M Caldwell","year":"2024","unstructured":"Caldwell M, Tisdale J, Khare R (2024) Improved recovery of nontuberculous mycobacteria in culture with adjunctive use of a selective agar. J Clin Microbiol 0:e01678-23","journal-title":"J Clin Microbiol"},{"key":"5361_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02736-23","volume":"0","author":"E Andr\u00e9","year":"2024","unstructured":"Andr\u00e9 E, Lorent N, Beuselinck K, Deiwick S, Dupont L, Gafsi J, Laenen L, Raymaekers L, Van Bleyenbergh P, Perry JD, Kahl BC (2024) Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis. Microbiol Spectr 0:e02736-23","journal-title":"Microbiol Spectr"},{"key":"5361_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01519-18","author":"S Rotcheewaphan","year":"2019","unstructured":"Rotcheewaphan S, Odusanya OE, Henderson CM, Stephenson D, Olivier KN, Perry JD, Zelazny AM (2019) Performance of RGM medium for isolation of nontuberculous mycobacteria from respiratory specimens from non-cystic fibrosis patients. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.01519-18","journal-title":"J Clin Microbiol"},{"key":"5361_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","volume":"125","author":"VN Dahl","year":"2022","unstructured":"Dahl VN, M\u00f8lhave M, Fl\u00f8e A, van Ingen J, Sch\u00f6n T, Lillebaek T, Andersen AB, Wejse C (2022) Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis 125:120\u2013131","journal-title":"Int J Infect Dis"},{"key":"5361_CR12","doi-asserted-by":"publisher","unstructured":"Zelazny AM, Balada-Llasat J-M (2023) MALDI-TOF MS for identification of acid-fast bacilli and aerobic actinomycetes. In: Leber\u00a0AL, Burnham C-AD (eds) Clinical microbiology procedures handbook, 5th edn. John Wiley & Sons, Ltd., vol 6.4, pp 1\u201315.\u00a0https:\/\/doi.org\/10.1002\/9781683670438.cmph0056","DOI":"10.1002\/9781683670438.cmph0056"},{"key":"5361_CR13","doi-asserted-by":"crossref","unstructured":"Martin I, Pfyffer GE, Parrish N (2023) Mycobacterium: general characteristics, laboratory processing, staining, isolation, and detection procedures,\u00a0In Manual of clinical microbiology 13th edition. John Wiley & Sons, Ltd., pp. 1\u201320","DOI":"10.1002\/9781683674849.mcm0030"},{"key":"5361_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K (2007) An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367\u2013416","journal-title":"Am J Respir Crit Care Med"},{"key":"5361_CR15","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ (2004) Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 42:3142\u20133146","journal-title":"J Clin Microbiol"},{"key":"5361_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/cid\/ciad214","volume":"77","author":"C Grigg","year":"2023","unstructured":"Grigg C, Jackson KA, Barter D, Czaja CA, Johnston H, Lynfield R, Vagnone PS, Tourdot L, Spina N, Dumyati G, Cassidy PM, Pierce R, Henkle E, Prevots DR, Salfinger M, Winthrop KL, Toney NC, Magill SS (2023) Epidemiology of pulmonary and extrapulmonary nontuberculous mycobacteria infections at 4 US emerging infections program sites: a 6-month pilot. Clin Infect Dis 77:629\u2013637","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05361-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:39:40Z","timestamp":1773495580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05361-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5361"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05361-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TIB, JRD, and CEM have no relevant conflicts of interest. SO is an employee for bioM\u00e9rieux Microbiology R&D and an inventor on a patent covering NTM Elite agar (EP3253885). MLY has received research grants from bioM\u00e9rieux and received consulting fees from BD and bioM\u00e9rieux. ARE has received research grants from bioM\u00e9rieux.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}